Symbols

ARMK

Aramark·NYSE

--(--)

ARMK fundamentals

ARMK Q1 2026 Earnings

Aramark (ARMK) released its earnings on Feb 10, 2026: revenue was 4.83B (YoY +6.14%), beat estimates; EPS was 0.51 (YoY 0.00%), beat estimates.

Revenue / YoY

4.83B

+6.14%

EPS / YoY

0.51

0.00%

Report date

Feb 10, 2026

ARMK Earnings Call Summary for Q1,2026

Revenue Momentum: 5% organic growth, driven by Workplace Experience and Corrections. Excluding calendar shift, growth would have been 8%.
Strategic Wins: Major health care contracts (Penn Medicine, RWJ Barnabas) and sports expansion (Welsh Rugby Union) highlight new business success.
Financial Targets: On track for FY26: 7-9% revenue growth, 12-17% AOI growth, 20-25% EPS growth. Q2 expects strong new business onboarding.
AI Efficiency: AI tools enhance supply chain and GPO performance, with minimal capital investment. Supports cost savings and operational scale.
Client Retention: Record-high retention rates, with 4-5% net new business target achievable.

Earnings

EPS

Revenue

Revenue & Expenses

ARMK has released its 2026 Q1 earnings report, with revenue of 4.83B, reflecting a YoY change of 6.14%, and net profit of 96.50M, showing a YoY change of -8.71%. The Sankey diagram below clearly presents ARMK's revenue sources and cost distribution.

Key Indicators

Aramark (ARMK) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Aramark (ARMK)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Aramark (ARMK)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Aramark (ARMK)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown